<b>Conclusions:</b> This study revealed the potential mechanism by which hypoxia-induced OPN<sup>+</sup> GAMs promote the mesenchymal transition in GBM cells and demonstrated the therapeutic potential of targeting OPN to enhance TMZ treatment effectiveness. The gene discussed is SPP1; the disease is glioblastoma.